MyoKardia, Inc. 4 SEC Filings

Filed On	Filing
19 Nov 2020	Form 4: Meeker David P, Director Disposed of 4,100 shares (Tender Offer) · Disposed of 53,600 Stock Option (Right to buy) (Disposition to Issuer)
19 Nov 2020	Form 4: McDowell Robert Scott, Chief Scientific Officer Disposed of 36,616 shares (Tender Offer) · Disposed of 433,904 Stock Option (Right to buy) (Disposition to Issuer)
19 Nov 2020	Form 4: Harris Taylor C., Chief Financial Officer Disposed of 42,559 shares (Tender Offer) · Disposed of 195,460 Stock Option (Right to buy) (Disposition to Issuer)
19 Nov 2020	Form 4: Agarwal Sunil, Director Disposed of 4,100 shares (Tender Offer) · Disposed of 64,600 Stock Option (Right to buy) (Disposition to Issuer)
19 Nov 2020	Form 4: Fairey William, EVP, Chief Commercial Officer Disposed of 42,199 shares (Tender Offer) · Disposed of 108,522 Stock Option (Right to buy) (Disposition to Issuer)
19 Nov 2020	Form 4: Bauer Jake, Chief Business Officer Disposed of 90,209 shares (Tender Offer) · Disposed of 197,021 Stock Option (Right to buy) (Disposition to Issuer)
19 Nov 2020	Form 4: Perry Mark L, Director Disposed of 29,508 shares (Tender Offer) · Disposed of 64,400 Stock Option (Right to buy) (Disposition to Issuer)
19 Nov 2020	Form 4: Popovits Kimberly J, Director Disposed of 4,100 shares (Tender Offer) · Disposed of 53,600 Stock Option (Right to buy) (Disposition to Issuer)
19 Nov 2020	Form 4: Cranston Mary B, Director Disposed of 4,100 shares (Tender Offer) · Disposed of 42,600 Stock Option (Right to buy) (Disposition to Issuer)
19 Nov 2020	Form 4: Gianakakos Anastasios, Director Disposed of 747,073 shares (Tender Offer) · Disposed of 1,088,912 Stock Option (Right to buy) (Disposition to Issuer)
19 Nov 2020	Form 4: Yarno Wendy L, Director Disposed of 5,508 shares (Tender Offer) · Disposed of 53,600 Stock Option (Right to buy) (Disposition to Issuer)
19 Nov 2020	Form 4: Waynick Denelle J, Chief Legal Officer Disposed of 25,000 shares (Tender Offer) · Disposed of 80,000 Stock Option (Right to buy) (Disposition to Issuer)
07 Jul 2020	Form 4: Gianakakos Anastasios, Director Sold 5,000 shares ($470K)
02 Jul 2020	Form 4: Waynick Denelle J, General Counsel Granted 80,000 Stock Option (Right to Buy) · Granted 25,000 Restricted Stock Units
01 Jul 2020	Form 4: Cranston Mary B, Director Received 371 shares by exercise or conversion ($4.34K) · Sold 371 shares ($36.6K) · Received 21,629 shares by exercise or conversion ($253K) · 1 more
22 Jun 2020	Form 4: Perry Mark L, Director Granted 3,000 Stock Option (Right to Buy) · Granted 1,800 Restricted Stock Units
22 Jun 2020	Form 4: Cranston Mary B, Director Granted 3,000 Stock Option (Right to Buy) · Granted 1,800 Restricted Stock Units
22 Jun 2020	Form 4: Agarwal Sunil, Director Granted 3,000 Stock Option (Right to Buy) · Granted 1,800 Restricted Stock Units
22 Jun 2020	Form 4: Popovits Kimberly J, Director Granted 3,000 Stock Option (Right to Buy) · Granted 1,800 Restricted Stock Units
22 Jun 2020	Form 4: Meeker David P, Director Granted 3,000 Stock Option (Right to Buy) · Granted 1,800 Restricted Stock Units

Comments